artemisinin has been researched along with Cardiac Remodeling, Ventricular in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 2 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Gu, Y; Huang, C; Wang, X; Wang, Y; Wu, G | 1 |
| Gu, Y; Hu, J; Huang, C; Tang, Y; Wang, X; Wu, G; Yuan, M | 1 |
2 other study(ies) available for artemisinin and Cardiac Remodeling, Ventricular
| Article | Year |
|---|---|
Artemisinin prevents electric remodeling following myocardial infarction possibly by upregulating the expression of connexin 43.
Topics: Animals; Anti-Infective Agents; Artemisinins; Connexin 43; Electric Stimulation; Male; Myocardial Infarction; Rats; Rats, Sprague-Dawley; RNA, Messenger; Survival Rate; Tumor Necrosis Factor-alpha; Ventricular Fibrillation; Ventricular Remodeling | 2014 |
Artemisinin attenuates post-infarct myocardial remodeling by down-regulating the NF-κB pathway.
Topics: Animals; Artemisinins; Blotting, Western; Cardiomegaly; Collagen Type I; Down-Regulation; Fibrosis; Hemodynamics; I-kappa B Proteins; Male; Matrix Metalloproteinase 2; Matrix Metalloproteinase 9; Myocardial Infarction; Myocardium; NF-kappa B; NF-KappaB Inhibitor alpha; Phosphorylation; Rats; Rats, Sprague-Dawley; Signal Transduction; Survival Analysis; Transforming Growth Factor beta1; Ultrasonography; Ventricular Remodeling | 2012 |